In order to elucidate the molecular basis of phenylketonuria (PKU) in Portugal, a detailed study of the Portuguese mutant phenylalanine hydroxylase (PAH) genes was performed. A total of 222 mutant alleles from 111 PKU families were analysed for 26 mutations and restriction fragment length polymorphismlvariable number tandem repeat (RFLP/VNTR) haplotypes. It was possible to characterise 55% of the mutant alleles, in which 14 different mutations (R261Q, V388M, IVSlOnt-11, I65T, P281L, R252W, R158Q, L348V, Y414C, L311P, Y198fsdel22bp, R408W, R270K, and R261X) and three polymorphisms (Q232Q, V245V, and L385L) were identified. A total of 14 different haplotypes were observed, with a high prevalence of haplotype 1 among mutant and normal alleles. The results reported in this study show considerable genetic heterogeneity in the Portuguese PKU population, as has also been described for other southern European populations.
Mutations in the phenylalanine hydroxylase (PAH; EC 1.14.16.1) gene are the molecular basis of phenylketonuria (PKU; McKusick MIM 261600), an autosomal recessive disorder which, in white populations, affects 1 in 10 000 livebirths. At present, far more than 300 different mutant alleles have been described at the PAH locus,' which cause different levels of reduction in the catalytic activity of the enzyme, generating a wide spectrum of clinical and biochemical phenotypes (genotypic and phenotypic heterogeneity). Data on the distribution and relative frequencies of the mutations affecting the PAH gene product have been described for various populations,25 and show marked interpopulation differences in mutational spectra. It has also been observed that some associations between mutations and haplotypes are population specific,6 which, when combined with the characterisation of the VNTR7 and STR8 alleles of the PAH gene, enable the formulation of hypotheses regarding the origin and spread of PKU mutations.
In Portugal, a neonatal screening programme for hyperphenylalaninaemia (HPA) was initiated in 1979 and has by now covered 1 576 869 newborns, 131 of whom were found to have classical PKU, corresponding to a frequency of 1/12 037.
In order to characterise the Portuguese PKU population at a molecular level, we started our analysis with screening for phenylalanine hydroxylase mutations by sequence analysis of exons 7 and 11, known to correspond to regions of the PAH gene containing a high number of mutations. Preliminary results9 showed the presence of several mutations described in European populations (R252W,'°R 261Q,10 P281L,11 12 IVSlOnt-1113 14), as well as two novel mutations, R270K and V388M.
In this study, we have extended the genetic analysis to PKU patients in all of Portugal in order to define the mutational spectrum of phenylalanine hydroxylase deficiencies in this country.
Materials and methods

PATIENTS AND FAMILIES
The present study included 111 hyperphenylalaninaemic children, born to unrelated, healthy parents, who originated from north Portugal (67) or south/central Portugal (48). Genomic DNA of the first group ofpatients was obtained from Guthrie cards, while that from the patients, and in some cases their families, living in the southern/central regions of the country was extracted from peripheral blood leucocytes.
The patients were classified, according to their initial phenylalanine levels, as having classical PKU (69 cases), mild PKU (35 cases), or non-PKU hyperphenylalaninaemia (seven cases).
Most of the patients (93 cases) were detected by the neonatal screening programme and, in every case, hyperphenylalaninaemia resulting from PAH deficiency was assessed after exclusion of tetrahydrobiopterin defiencies. The other 18 patients were born before 1980 and were clinically classified as having classical PKU. Two normal and two mutant alleles were accounted for per family. All of the 111 patients were white.
HAPLOTYPE ANALYSIS
The Southern blotting technique was used for the detection of the EcoRI and EcoRV polymorphisms; the full length cDNA probe phPAH247's was labelled with [32P]dCTP (Amersham, UK) using the random priming method (Pharmacia Biotech, Uppsala, Swe- (Boehringer Mannheim, Germany).
Results
MUTATION ANALYSIS
Screening for 23 mutations and three polymorphisms (table 1), previously described in other white populations, allowed the identification of the three polymorphisms and 14 of these mutations in the Portuguese population. Table  2 shows that 55% (122/222) of all PKU alleles studied were found to carry a previously identified mutation and that there is no one mutation(s) prevalent in the Portuguese PKU population; rather three groups of mutations exist for which relative frequencies are 9-11 % (IVS1Ont-11, R261Q, V388M), 3-6% (I65T, P281L, R252W, R158Q), and below 2% (L348V, Y414C, L311P, Y198fsdel22, R408W, R270K, R261X), respectively.
Previously described diallelic polymorphisms were identified in the Portuguese population in codons 232, 245, and 385. The frequencies of these polymorphisms were found to be 10.4% for the G allele and 89.6% for the A allele of the Q232Q polymorphism, 9.4% for the A allele and 90.6% for the G allele of the V245V polymorphism, and 3.2% for the C allele and 96.8% for the G allele of the L385L polymorphism.
Determination Each of the mutations found in the Portuguese PKU population was strongly associated with a single RFLP/VNTR haplotype, except for the R408W and I65T mutations. The first mutation was observed on the background of haplotypes 1.8 and 2.3 (once in both cases), while the I65T mutation was found in association with haplotype 9.8 and once with haplotype 57.8. Interestingly, I65T was associated with the same VNTR allele in both haplotypes.
Six mutations (R252W, R261Q, R270K, P281L, V388M, R408W) were detected associated with haplotype 1 alleles, which comprise 64.6% of the mutant alleles in the Portuguese population, three mutations associated with haplotype 4 (RI 58Q, R261X, Y414C) and two mutations on the background of haplotype 9 (I65T, L348V) alleles.
As in other populations, the diallelic polymorphisms detected in our sample were strongly associated with specific haplotypes: Q232Q with haplotypes 3, 4, and 7; V245V exclusively with haplotype 4; and L385L with haplotypes 3 and 7.
Discussion
The results obtained in the present study con Recently, a detailed study of the PAH mutation profile of the Spanish population has been published. 35 Comparing the Portuguese and the Spanish mutational spectra, it is obvious that the four major mutations are common to both populations and that they are found on the background of the same main haplotypes (IVS1Ont-11/H6.7; R261Q/Hl.8; V388M/ H1.7; I65T/H9.8). Regarding the other mutations present in both populations, their incidence is markedly different and, interestingly, most of them are in association with different haplotypes; this is the case with the L3 1 1 P and the R252W mutations, associated with haplotypes 3.8 and 1.8, and haplotypes 17.9/7.9 and X.3, respectively, in Portugal and in Spain. There are also five mutations present in the Portuguese population that are completely absent from the Spanish sample, particularly the RI 58Q and the L348V mutations, found at a relatively high frequency in Portugal.
Of particular interest is the observed absence of the A403V mutation in the Portuguese HPA patients, because this mutation is described as the most frequent one among southern European non-PKU HPA patients.25 36 Until now, none of the already described non-PKU mutations has been identified in our population.
The present information regarding the Portuguese HPA population, together with the above mentioned study on the mutation profile in Spain, seems to prove that both populations, though very closely situated, have received distinct ethnic influences throughout history.
In conclusion, the present study provides data for a population genetic analysis of the distribution and spread of PKU mutations in southern Europe, where Portugal assumes a unique position with regard to its composition of PKU alleles.
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